Brandywine Global Investment Management, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 141 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brandywine Global Investment Management, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,539,173
-11.1%
217,209
+2.2%
0.02%
-8.3%
Q2 2023$2,856,121
-59.7%
212,509
-50.2%
0.02%
-17.2%
Q1 2023$7,079,958
+78.3%
427,018
+100.0%
0.03%
-6.5%
Q4 2022$3,971,267
+45.0%
213,5090.0%0.03%
+19.2%
Q3 2022$2,739,000
+75.8%
213,509
-3.9%
0.03%
+85.7%
Q2 2022$1,558,000
-26.2%
222,267
-12.7%
0.01%
-6.7%
Q1 2022$2,111,000
+22.4%
254,6670.0%0.02%
+25.0%
Q4 2021$1,724,000
-7.5%
254,667
-27.6%
0.01%
-14.3%
Q3 2021$1,864,000
-7.3%
351,642
+0.6%
0.01%
-6.7%
Q2 2021$2,010,000
+23.2%
349,628
-1.2%
0.02%
+25.0%
Q1 2021$1,631,000
+36.7%
353,887
-1.0%
0.01%
+20.0%
Q4 2020$1,193,000
-10.7%
357,325
-20.5%
0.01%
-23.1%
Q3 2020$1,336,000
-15.2%
449,680
+32.0%
0.01%
-18.8%
Q2 2020$1,575,000
+21.2%
340,790
+1.0%
0.02%0.0%
Q1 2020$1,300,000
+2.8%
337,562
+0.6%
0.02%
+77.8%
Q4 2019$1,265,000
-15.4%
335,412
+19.1%
0.01%
-18.2%
Q3 2019$1,496,000
+11.6%
281,677
-19.3%
0.01%
+22.2%
Q2 2019$1,341,000
+23.1%
349,072
+63.5%
0.01%
+12.5%
Q1 2019$1,089,000213,4750.01%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders